Molecular epidemiology: Low-dose carcinogens and genetic susceptibility

International Journal of Cancer

Volumn 71, Issue 1, 1997, Pages 1-3

  Vineis, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHEMICAL AGENT; TOBACCO SMOKE;

CANCER; CANCER EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; OCCUPATIONAL EXPOSURE; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING;

CARCINOGENS, ENVIRONMENTAL; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; ONCOGENES; SMOKING;

EID: 0030932612     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970328)71:1<1::AID-IJC1>3.0.CO;2-Y     Document Type: Short Survey

References (18)

1. BROCKMOLLER, J., KERB, R., DRAKOULIS, N., NITZ, M. and ROOTS, I., Genotype and phenotype of glutathione-S-transferase class mu isoenzymes mu and psi in lung-cancer patients and controls. Cancer Res., 53, 1004-1011 (1993).
2. BROCKMOLLER, J., KERB, R., DRAKOULIS, N., STAFFELDT, B. and ROOTS, I., Glutathione-S-transferase M1 and its variants A and B as host factors of bladder-cancer susceptibility: a case-control study. Cancer Res., 54, 4103-4111 (1994).
3. CAPORASO, N., LANDI, M.T. and VINEIS, P., Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics, 1, 4-19 (1991).
4. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S. and VAINIO, H., The GSTM1 null genotype as a potential risk modifier for squamous-cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481 (1993).
5. KATO, S., BOWMAN, E.D., HARRINGTON, A.M., BLOMEKE, B. and SHIELDS, P.G., Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. nat. Cancer Inst., 87, 902-907 (1995).
6. KELSEY, K.T., WIENCKE, J.K. and SPITZ, M.R., A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis, 15, 1121-1124 (1994).
7. KIHARA, M., KIHARA, M. and NODA, K., Lung-cancer risk of GSTM1 null genotype is dependent on the extent of tobacco-smoke exposure. Carcinogenesis, 15, 415-418 (1994).
8. KOUHRY, M.J. and WAGENER, D.K., Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Amer. J. Epidemiol., 137, 1241-1250 (1993).
9. LONDON, S.J., DALY, A.K., COOPER, J., NAVIDI, W.C., CARPENTER, C.L. and IDLE, J.R., Polymorphism of glutathione-S-transferase M1 and lung-cancer risk among African-Americans and Caucasians in Los Angeles county, California. J. nat. Cancer Inst., 87, 1246-1253 (1995).
10. NAKACHI, K., IMAI, K., HAYASHI, S. and KAWAJIRI, K., Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999 (1993).
11. NAKACHI, K., IMAI, K., HAYASHI, S., WATANABE, J. and KAWAJIRI, K., Genetic susceptibility to squamous-cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180 (1991).
12. NAZAR-STEWART, V., MOTULSKY, A.G., EATON, D.L., WHITE, E., HORNUNG, S.K., LENG, Z.T., STAPLETON, P. and WEISS, N.S., The glutathione-S-transferase M polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318 (1993).
13. POTT, F. and HEINRICH, U., Relative significance of different hydrocarbons for the carcinogenic potency of emissions from various incomplete combustion processes. In: H. Vainio, M. Sorsa and A.J. McMichael (eds.), Complex mixtures and cancer risk. IARC Scientific Publication 104, IARC, Lyon (1990).
14. SHIELDS, P.G., CAPORASO, N.E., FALK, R.T., SUGIMURA, H., TRIVERS, G., TRUMP, B.F., HOOVER, R.N., WESTON, A. and HARRIS, C.C., Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol., Biomarkers Prev., 2, 481-485 (1993).
15. SUGIMURA, H., SUZUKI, I., HAMADA, G.S., IWASE, T., TAKAHASHI, T., NAGURA, K., IWATA, H., WATANABE, S., KINO, I. and TSUGANE, S., Cytochrome P-450 1A1 genotype in lung-cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol., Biomarkers Prev., 3, 145-148 (1994).
16. TAIOLI, E., CROFTS, F., TRACHMAN, J., DEMOPOULOS, R., TONIOLO, P. and GARTE, S.J., A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55, 472-473 (1995).
17. VINEIS, P., BARTSCH, H., CAPORASO, N., HARRINGTON, A., KADLUBAR, F.F., LANDI, M.T., MALAVEILLE, C., SHIELDS, P., SKIPPER, P., TALASKA, G. and TANNENBAUM, S.R., Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369, 154-156 (1994).
18. VINEIS, P. and MCMICHAEL, A.J., Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the aetiology of colon cancer. Cancer Causes Control, 7, 479-486 (1996).